The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars)
Imago Biosciences, Inc. total equity 2019-2021
The total equity of Imago Biosciences, Inc. with headquarters in the United States amounted to * million U.S. dollars in 2021. The reported fiscal year ends on December 31.
Compared to the earliest depicted value from 2019 this is a total increase by approximately * million U.S. dollars. The trend from 2019 to 2021 shows, however, that this increase did not happen continuously.
Compared to the earliest depicted value from 2019 this is a total increase by approximately * million U.S. dollars. The trend from 2019 to 2021 shows, however, that this increase did not happen continuously.
Log in or register to access precise data.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Inhibrx total equity 2019-2023
- Premium Statistic Immunovant, Inc. total equity 2021-2025
- Premium Statistic Jaguar Health total equity 2021-2025
- Premium Statistic Immunogen, Inc. total equity 2018-2022
- Premium Statistic Innovation1 Biotech total equity 2019-2023
- Premium Statistic Innoviva total equity 2021-2025
- Premium Statistic Kaleido Biosciences, Inc. total equity 2017-2021
- Premium Statistic Jounce Therapeutics, Inc. total equity 2018-2022
- Premium Statistic Kalvista Pharmaceuticals total equity 2021-2025
- Premium Statistic Kintara Therapeutics total equity 2021-2025
About the region
10
- Premium Statistic Information Services Group total equity 2021-2025
- Premium Statistic Investcorp Credit Management Bdc, Inc. total equity 2022-2025
- Premium Statistic Innoveren Scientific total equity 2018-2022
- Premium Statistic International Land Alliance Inc. total equity 2021-2025
- Premium Statistic Inozyme Pharma total equity 2020 to 2024
- Premium Statistic Iron Mountain Inc total equity 2021-2025
- Premium Statistic Invivyd total equity 2021-2025
- Premium Statistic Immunome total equity 2021-2025
- Premium Statistic Investview total equity 2021-2025
- Premium Statistic Inogen total equity 2021-2025
Selected statistics
10
- Premium Statistic Invitae total equity 2018-2022
- Premium Statistic Meridian Bioscience Inc total equity 2018-2022
- Premium Statistic Alcon total equity 2021-2025
- Premium Statistic China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. total equity 2021-2025
- Premium Statistic Bausch Health Companies total equity 2021-2025
- Premium Statistic Neogen total equity 2021-2025
- Premium Statistic Laboratorios Farmaceuticos Rovi total equity 2019-2023
- Premium Statistic Stada Arzneimittel total equity 2019 to 2023
- Premium Statistic C.H. Boehringer Sohn total equity 2018 to 2022
- Premium Statistic Sandoz Deutschland total equity 2019 to 2023
Other regions
10
- Premium Statistic Riverfort Global Opportunities total equity 2019-2020
- Premium Statistic Safari Industries (India) Limited total equity 2021-2025
- Premium Statistic Sakthi Sugars Limited total equity 2021-2025
- Premium Statistic Sastasundar Ventures Limited total equity 2020-2024
- Premium Statistic Sansera Engineering Limited total equity 2021-2025
- Premium Statistic Sangam (India) Limited total equity 2021-2025
- Premium Statistic Rupa & Company Limited total equity 2021-2025
- Premium Statistic Spencer's Retail Limited total equity 2021-2025
- Premium Statistic The Bombay Dyeing and Manufacturing Company Limited total equity 2021-2025
- Premium Statistic Siyaram Silk Mills Limited total equity 2021-2025
Related statistics
10
- Premium Statistic Invivo Therapeutics Holdings total equity 2018-2022
- Premium Statistic Iridex total equity 2021-2025
- Premium Statistic Ivanhoe Electric total equity 2021-2025
- Premium Statistic Intellicheck total equity 2021-2025
- Premium Statistic Independent Bank Group total equity 2019-2023
- Premium Statistic Inhibitor Therapeutics total equity 2021-2025
- Premium Statistic Inmune Bio total equity 2021-2025
- Premium Statistic Investar Holding total equity 2021-2025
- Premium Statistic Janel Corp total equity 2021-2025
- Premium Statistic Intrepid Potash total equity 2021-2025
Further Content: You might find this interesting as well
U.S. Securities and Exchange Commission. (October 24, 2024). Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 23, 2026, from /forecasts/1501837/imago-biosciences-inc-total-equity/
U.S. Securities and Exchange Commission. "Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars)." Chart. October 24, 2024. ÌÇÐÄÆÆ½â°æ. Accessed July 23, 2026. /forecasts/1501837/imago-biosciences-inc-total-equity/
U.S. Securities and Exchange Commission. (2024). Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 23, 2026. /forecasts/1501837/imago-biosciences-inc-total-equity/
U.S. Securities and Exchange Commission. "Total Equity of Imago Biosciences, Inc. from 2019 to 2021 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 24 Oct 2024, /forecasts/1501837/imago-biosciences-inc-total-equity/
U.S. Securities and Exchange Commission, Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /forecasts/1501837/imago-biosciences-inc-total-equity/ (last visited July 23, 2026)
Total equity of Imago Biosciences, Inc. from 2019 to 2021 (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, October 24, 2024. [Online]. Available: /forecasts/1501837/imago-biosciences-inc-total-equity/
Advertisement









